Blog Archives

Silent takedown of the pharma trials database…and more

Category: General, Public, Research Ethics | Tagged , , , , , | Leave a comment

Pharmaceutical R&D’s Costly Myths

Category: General | Tagged , , , | Leave a comment

This Week in PLoS Medicine: WHO’s PMTCT; WTO compulsory licenses; & more

Category: General, PLoS Medicine Week by Week | Tagged , , , , , , , , , , , | Leave a comment

The business of vaccines

Category: General, Policy, Public | Tagged , , , | Leave a comment

This Week in PLoS Medicine: H1N1 response in Mexico; Med students & pharma marketing; Migration & Health

Category: PLoS Medicine Week by Week | Tagged , , , , , , | Leave a comment

If You Can’t Afford Your Medication

Category: drug cost, Patient Assistance Programs, Pharmaceutical supply chain | Tagged , , , , , , , , , , , | Leave a comment

Patent pool party highlights lack of access to HIV drugs

Category: General, Students | Tagged , , , | Leave a comment

Collaborative Clinical Trials: A Way Forward?

Category: Drug Development | Tagged , , , , , , , , , | Leave a comment

This Week in PLoS Medicine: Economic growth in India; Predictions from translational trials

Category: PLoS Medicine Week by Week | Tagged , , , , | Leave a comment

Is funding into Neglected Diseases being misdirected?

Category: General, Neglected Diseases, Policy | Tagged , , , , , | Leave a comment